NCT02559752: Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 4 Years to 21 Years (Child, Adult)
Location of Metastases: Brain
Additional Notes: Patients must be planning to receive proton beam radiation therapy (PBRT) to treat the central nervous system (CNS) tumor
Exclusions: Patients over 21 years of age

Comments are closed.

Up ↑